The company views ESG reporting as a strategic tool to build trust with clients, investors, regulators, and stakeholders worldwide
Intas becomes the first and only company in India to offer IVF and gynecology therapies with needle-free injections
Nona aims to help global biopharmaceutical companies fast-track clinical trial initiation without compromising scientific rigor or quality standards
Healthcare and insurance are not parallel systems; they are interdependent pillars of patient trust
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
Bertozzi currently serves as the Baker Family Director of Sarafan ChEM-H, Anne T. and Robert M. Bass Professor at Stanford University, and Investigator of the Howard Hughes Medical Institute
The EIR was issued following an inspection of the facility from September 8 to September 16, 2025
If approved, CUTX-101 will be the first and only FDA approved treatment available for Menkes disease
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
Subscribe To Our Newsletter & Stay Updated
